Trademark Overview
On Monday, June 15, 2026, a trademark application was filed for HYALUTE with the United States Patent and Trademark Office. The USPTO has given the HYALUTE trademark a serial number of 99886234. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 15, 2026. This trademark is owned by Prohibix LLC. The HYALUTE trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of injectable, topical, transdermal, mucosal, and suppository form that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations in the form of injectable, topical, transdermal, mucosal, and suppository for the treatment of inflammatory and degenerative tissue diseases, musculoskeletal and orthopedic disorders, cardiovascular diseases, dermatological conditions, wounds, fibrotic disorders, gastrointestinal, urogenital, rectal, vaginal, and mucosal inflammatory diseases and disorders, pain, inflammation, tissue injury, tissue degeneration, and tissue remodeling
